x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:11:48

My Perspective: Living With HIV Is Life Changing but...

Decera Clinical Education Infectious Disease Podcast ·

2022/06/21

In this episode, Yvette Raphael provides her perspectives and advice as an individual living with HIV in South Africa for more than 20 years. She shares her experiences and ideas for how to improve processes related to HIV diagnosis, care linkage, and treatment.Presenter:Yvette RaphaelContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/3tmgozy

en

00:13:55

When Patients With Chronic HBV Infection Do Not Meet...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/26

In this episode, Pietro Lampertico, MD, PhD, discusses what to do when treatment for hepatitis B virus (HBV) infection is not indicated, covering topics such as:The different phases of chronic HBV infectionWhich patients in different phases require immediate HBV treatment and which can be monitored without therapyThe critical importance of ongoing monitoring for patients who do not meet indications for immediate therapyThe tests and frequency that should be used for monitoring patients not

en

00:25:20

Key Decisions in HIV Care: Postexposure Prophylaxis

Decera Clinical Education Infectious Disease Podcast ·

2022/05/26

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).Listen as she gives perspectives on:The CDC algorithm for evaluation and treatment of potential HIV exposuresThe CDC guideline preferred and alternative PEP antiretroviral therapy regimensData for the use of the single-tablet regimen bictegravir/emtricitabine/tenofovir alafenamide for PEPRecommended laboratory monitoring with PEPThe initiation of

en

00:28:12

Key Decisions in HIV Care: Treatment Considerations...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/25

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for transgender people with HIV (PWH).Listen as she gives perspectives on:Department of Health and Human Services (DHHS) guideline recommendations for transgender PWHProviding HIV care within a gender-affirmative care model, including discussion of strategies, barriers, and facilitatorsGender-affirmative hormone therapy optionsDrug–drug interaction potential between gender-affirmative hormone therapy and

en

00:20:44

Key Decisions in HIV Care: Choosing ART for Pediatric...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/25

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatric patients.Listen as she gives perspectives on:Department of Health and Human Services (DHHS) guideline recommendations for infants at risk for perinatal HIV transmissionDHHS guideline–recommended ART regimens for childrenThe ODYSSEY A and B studies evaluating dolutegravir-based ART in children and adolescentsData for the use of the fixed-dose

en

00:35:19

COVID-19: Outpatient Therapeutic Updates

Decera Clinical Education Infectious Disease Podcast ·

2022/05/24

In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses: Principles for antiviral agent use in nonhospitalized patientsPreferred and alternative treatment optionsTreatment prioritization when there are logistical or supply constraintsOutpatient remdesivir usePINETREE data (adult patients)CARAVAN data (pediatric patients)FDA approval and treatment candidacyTherapeutic updatesIvermectin and the TOGETHER studyMonoclonal antibody use during current omicron eraPresenter: Sharon R. Lewin, AO,

en

00:13:46

RSV in Older Adults: Immunology and Vaccine Development

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, Dexter James Wiseman, MD, discusses immunology and RSV vaccine development for older adults, including:Need for a vaccineEconomic burden of RSVReasons for poor outcomes in older adultsInvestigational vaccinesPresenter: Dexter James Wiseman, MDClinical Research FellowNHLIImperial CollegePhysicianRespiratory MedicineRoyal Brompton HospitalLondon, United KingdomReview the downloadable slideset and the full program at: https://bit.ly/3ydC8Ri

en

00:14:57

RSV in Older Adults: Epidemiology and Risk Factors

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, Dexter James Wiseman, MD, discusses the epidemiology and risk factors for RSV in older adults, including:OverviewDisease burden based on ageSeasonalityImpact in care facilitiesEffects of the COVID-19 pandemicPresenter: Dexter James Wiseman, MDClinical Research FellowNHLIImperial CollegePhysicianRespiratory MedicineRoyal Brompton HospitalLondon, United KingdomReview the downloadable slideset and the full program at: https://bit.ly/3ydC8Ri

en

00:13:56

RSV in Older Adults: Identification and Impact

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, Dexter James Wiseman, MD, discusses the impact and diagnosis of RSV in older adults, including:Risk factors for poor outcomesRSV vs influenza outcomesRSV symptomsRSV diagnosticsPresenter: Dexter James Wiseman, MDClinical Research FellowNHLIImperial CollegePhysicianRespiratory MedicineRoyal Brompton HospitalLondon, United KingdomReview the downloadable slideset and the full program at: https://bit.ly/3ydC8Ri

en

00:09:04

Adult HBV Vaccination: Current Vaccines and...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, listen as Robert G. Gish, MD, discusses key information on comparing current HBV vaccine formulations, and learn the best immunization practices for routine vaccination, including in special situations.Presenter:Robert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaAdjunct Professor of MedicineNevada School of MedicineLas Vega, NevadaClinical ProfessorUniversity of Nevada Reno School of MedicineReno, NevadaClinical ProfessorUniversity of California

en

00:10:32

Adult HBV Vaccination: Identifying Individuals at...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV vaccine recommendations in special populations. Listen as Robert G. Gish, MD, discusses key information on the identification and evaluation of patients who have chronic health conditions and therefore may be at risk for nonresponse to available vaccines.Presenter: Robert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda,

en

00:12:02

Adult HBV Vaccination: Overcoming Gaps to Lessen the...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/05

In this episode, learn about the importance of hepatitis B virus (HBV) vaccination in adults. Listen as Robert G. Gish, MD, discusses key data on the burden and impact of HBV infection, and strategies to overcome barriers to HBV vaccination.Robert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaAdjunct Professor of MedicineNevada School of MedicineLas Vega, NevadaClinical ProfessorUniversity of Nevada Reno School of MedicineReno, NevadaClinical ProfessorUniversity of

en

00:13:56

Increasing Awareness of Hepatitis Delta

Decera Clinical Education Infectious Disease Podcast ·

2022/05/03

Hepatitis delta virus (HDV) is the most severe form of viral hepatitis, yet many patients go undiagnosed. Increasing HDV awareness is an important step to correct this and ensure that at-risk patients receive screening and then treatment and monitoring following a positive test. Hear Grace LH Wong, MD, and Ming-Lung Yu, MD, PhD, discuss a call to action to increase healthcare professional and patient awareness of HDV. Presenters: Grace LH Wong, MDProfessorDirector, Medical Data Analytics Centre

en

00:18:16

Why Everyone Should Be Screened for HCV and Treated...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/03

In this episode, Norah Terrault, MD, MPH, and a patient who has been cured of hepatitis C virus (HCV) infection discuss the importance of universal HCV testing for all adults, as well as the ease of curative therapies and the benefits of living with improved liver function post cure. This insightful discussion underscores how perceptions around HCV transmission risks and lack of symptoms serve as barriers to adequate screening and diagnosis, preventing curative treatment for many people with

en

00:49:18

Key Decisions in HIV Care: Considering Novel...

Decera Clinical Education Infectious Disease Podcast ·

2022/05/02

In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss novel therapies for HIV prevention and treatment, including: PreventionCabotegravir for pre-exposure prophylaxis (PrEP) with the latest results from the HPTN 083 and HPTN 084 studiesNovel PrEP therapies in development, including islatravir and lenacapavirInitial therapyLenacapavir for initial therapy with results from the CALIBRATE studySwitch strategiesCabotegravir as a

en

00:22:06

A Model Intervention: Aiming for HCV Elimination in...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/27

In this podcast, Dr Dominique Laurent Braun discusses his micro-elimination program, the Swiss HCVree trial, designed to prevent hepatitis C virus (HCV) transmission among HIV-positive men who have sex with men. The study employed a test-and-treat approach to eliminate HCV infection in this key target population and could be a model for other countries to eliminate HCV infection in certain populations.Presenter:Dominique Laurent Braun, MDSenior Staff PhysicianDivision of Infectious Diseases and

en

00:23:17

COVID-19: Which Drug, When, and Why? Antiviral Agents

Decera Clinical Education Infectious Disease Podcast ·

2022/04/25

Antiviral agents continue to be effective against different strains of SARS-CoV-2 when used early in the disease course. In this episode, learn about the role of antiviral agents in hospitalized and high-risk nonhospitalized patients with COVID-19 and in different age groups. Listen as David A. Wohl, MD, discusses when and how to use IV and oral antiviral agents including:Nirmatrelvir + ritonavirRemdesivirMolnupiravirPresenter:David A. Wohl, MDProfessor of MedicineSchool of MedicineSite Leader,

en

00:30:01

COVID-19: Which Drug, When, and Why? Monoclonal...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/21

The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of complications from acquiring COVID-19 or treatment of high-risk patients who have a mild to moderate COVID-19 infection. Listen as Gregory Huhn, MD, MPHTM, discusses when and how to use monoclonal antibodies including:BebtelovimabCilgavimab/tixagevimabSotrovimabPresenter:Gregory Huhn, MD, MPHTMAssociate ProfessorDepartment of Infectious DiseasesRush

en

00:19:51

How Stigma and Socioeconomic Barriers Impede HCV...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/20

In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and a patient with previous injection drug use who has been cured of HCV infection discuss critical barriers that are preventing more people with current or previous injection drug use from receiving appropriate HCV care.This insightful discussion underscores the negative effects of stigma toward people who inject drugs that exist in many clinical settings, the important role that socioeconomic factors such as transportation access and stable

en

00:38:54

Long COVID

Decera Clinical Education Infectious Disease Podcast ·

2022/04/13

In this episode, Renslow Sherer, MD, discusses what is known to date regarding long COVID, also known as postacute sequelae of COVID-19 infection, including:Possible causes and risk factorsSigns and symptomsClinical managementTreatment options under considerationRole of vaccinationPresenter: Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisReview the

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College